| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.04.24 | Wipro Limited: Wipro ernennt Srini Pallia zum CEO und Geschäftsführer | 922 | Business Wire | Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), ein führendes Technologie- und Beratungsunternehmen, gab heute die Ernennung von Srini Pallia zum Chief Executive Officer und Geschäftsführer des... ► Artikel lesen | |
| 06.04.24 | Bristol Myers Squibb Presents New Pooled Interim Long-Term Safety and Metabolic Outcomes Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society | 1.142 | Business Wire | KarXT demonstrated a favorable long-term metabolic profile where most patients experienced stability or improvements on metabolic parameters over 52 weeks of treatment A majority of patients (65%)... ► Artikel lesen | |
| 06.04.24 | Bristol Myers Squibb Presents New Interim Long-Term Efficacy Data from the EMERGENT-4 Trial Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society | 1.128 | Business Wire | Long-term treatment with KarXT was associated with continued improvements in symptoms of schizophrenia across all efficacy measures at 52 weeks More than 75% of participants achieved 30% improvement... ► Artikel lesen | |
| 06.04.24 | Teva Pharmaceutical Industries Limited: New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY (risperidone) Extended-Release Injectable Suspension at SIRS 2024 | 1.272 | Business Wire | PK modeling data provide insights into potential dosing conversions and strategies for switching to UZEDY from a long-acting injectable (LAI) formulation of risperidone microspheres (R064766)... ► Artikel lesen | |
| 06.04.24 | Daiichi Sankyo: ENHERTU Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors | 2.227 | Business Wire | Based on three phase 2 trials of Daiichi Sankyo and AstraZeneca's ENHERTU that showed clinically meaningful responses across a broad range of tumors
ENHERTU now has five approved indications... ► Artikel lesen | |
| 06.04.24 | SSR Mining Inc.: SSR Mining Provides Update on Çöpler Incident | 1.498 | Business Wire | SSR Mining Inc. (Nasdaq/TSX: SSRM; ASX: SSR) ("SSR Mining" or the "Company") provides an update on the ongoing recovery efforts at the Çöpler mine in Türkiye.
Since the February 13, 2024 incident... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 3.620 |
| TESLA | 2.788 |
| RHEINMETALL | 1.588 |
| RENK GROUP | 1.393 |
| TUI | 1.371 |
| BYD | 1.339 |
| THYSSENKRUPP | 1.244 |
| STEYR MOTORS | 1.217 |
| APPLE | 1.196 |
| PUMA | 1.194 |
| DEUTZ | 1.161 |
| AMAZON | 1.137 |
| NEL | 1.136 |
| VOLKSWAGEN | 1.033 |
| BASF | 982 |
| MERCEDES-BENZ | 882 |
| NIKE | 825 |
| EVOTEC | 788 |
| BAYER | 775 |
| NOVO NORDISK | 683 |
| AIXTRON SE | 682 |
| DEUTSCHE BANK | 677 |
| NORDEX | 672 |
| PORSCHE AG | 658 |
| XIAOMI | 642 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
